Le Lézard
Classified in: Ebola virus, Health, Science and technology, Covid-19 virus

AHF: WHO's Monkeypox Name Game is Mistimed


AIDS Healthcare Foundation today called on the World Health Organization (WHO) to prioritize implementing proven public health measures to curb the global spread of monkeypox, instead of devoting time and energy to changing the name that was given to the virus in 1958.

"WHO says monkeypox must be renamed because it may be perceived as derogatory, but sadly that doesn't change the fact that this disease was of little concern to the global health establishment in Geneva until people in wealthy countries started getting infected in large numbers ? a pattern we have seen before with HIV, Ebola, and COVID-19," said AHF President Michael Weinstein. "This begs the question, if actions speak louder than words, is WHO's referendum on the name ?monkeypox' nothing more than a token gesture? We need to bring back the basics of public health - education, prevention, training, treatment, and research."

Homophobia has been far more damaging to public health efforts to combat monkeypox than the name scientists assigned to the virus decades ago?quite logically?because it was first observed in monkeys. The virus has disproportionately affected gay and bisexual men, which has given countries and public health authorities in many jurisdictions cover to ignore the outbreak for far too long, either out of negligence or unwillingness to acknowledge that their populations have men who have sex with men. WHO itself waited 10 weeks to declare monkeypox a public health emergency of international concern (PHEIC), and even then it was deadlocked on the decision until Director-General Tedros intervened.

If WHO is serious about decolonizing public health, it would do well to step out of the Geneva bubble and speak out on issues of pervasive systemic racism and discrimination with respect to how the world handles outbreaks, which are of greater immediate consequence in terms of saving lives and preventing illness and suffering than names of viruses. The time to debate scientific and social merits of renaming diseases like monkeypox, chickenpox, bird flu, swine flu, Middle East Respiratory Syndrome (MERS), West Nile Virus, yellow fever, and others to avoid stigma associated with animals, regions, ethnicity, colors, and so on, will come, but there are more pressing needs at hand.

AIDS Healthcare Foundation (AHF) is a global non-profit organization providing cutting-edge medicine and advocacy to over 1.6 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. We are currently the largest non-profit provider of HIV/AIDS medical care in the world. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare


These press releases may also interest you

at 23:05
OKX, a leading Web3 technology company, today announced the integration of Biturbo with the OKX Wallet. Bitrubo is an innovative layer 2 solution that brings the power of Ethereum's smart contracts to the Bitcoin network. Biturbo is designed as an...

at 23:03
The report titled "Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical - Global Forecast 2024-2030" is now available on...

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...



News published on and distributed by: